Nateglinide
Nateglinide is an amino acid-derived oral hypoglycemic agent used to treat type 2 diabetes by stimulating pancreatic insulin secretion. It is employed in research on diabetes pathophysiology and drug mechanisms, both in vitro and in animal models. Rare cases of clinically apparent acute liver injury have been associated with its use.
Product Specifications
CAS Number
105816-04-4
Product Name Alternative
Dipeptidyl Peptidase, diabetes, DPP, A4166, A-4166, A 4166, glucose, Inhibitor, insulin, inhibit, KcsA, Nateglinide, β-cell, short-acting, Potassium Channel, Senaglinide, PotassiumChannel, PPARγ
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.78% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.3 mM) ; DMSO:60 mg/mL (189.02 mM)
Smiles
C (N[C@H] (CC1=CC=CC=C1) C (O) =O) (=O) [C@H]2CC[C@H] (C (C) C) CC2
Molecular Formula
C19H27NO3
Molecular Weight
317.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15290865 1 Vial
Lentiviral mouse Tbx18 shRNA (UAS) - Lentiviral mouse Tbx18 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 